Results for tag: "Digoxin Test"

The Digoxin Test is an in vitro diagnostic test used to measure the amount of the drug digoxin in a patient's blood. It is used to monitor the effectiveness of digoxin therapy and to detect toxicity. The test is typically performed on a sample of blood taken from a patient's vein. The sample is then analyzed in a laboratory using a variety of methods, including enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), and high-performance liquid chromatography (HPLC). The Digoxin Test market is a segment of the larger in vitro diagnostics market, which is estimated to be worth billions of dollars. The market is driven by the increasing prevalence of chronic diseases, such as heart failure, and the need for accurate and timely diagnosis. The market is also driven by the increasing demand for point-of-care testing and the development of new technologies, such as digital PCR. Some of the major companies in the Digoxin Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, and Sysmex Corporation. Show Less Read more